{
  "drug_name": "Aspirin",
  "summary": {
    "overall_insight": "Aspirin shows significant repurposing potential based on recent research and market analysis."
  },
  "clinical_trials": {
    "total_trials": 0,
    "trials_by_disease": {},
    "key_trials": [],
    "summary": "Exploration of nanotechnology for aspirin delivery (nanosensors), repurposing for cancer therapy via structural modifications (anthraquinone derivatives), and ongoing studies on preventive roles in preeclampsia."
  },
  "research_papers": {
    "total_papers": 3,
    "key_topics": [
      "Novel anthraquinone-based aspirin derivatives with anti-cancer activity"
    ],
    "top_papers": [
      {
        "title": "Prevention of preeclampsia.",
        "year": 2024,
        "authors": [
          "Brownfoot F",
          "Rolnik DL"
        ],
        "url": "https://pubmed.ncbi.nlm.nih.gov/38373378/"
      },
      {
        "title": "Aspirin nanosensors.",
        "year": 2025,
        "authors": [
          "Koohkansaadi G",
          "Tabean M",
          "Mohagheghi A",
          "Masoumi S",
          "Jahanabad ZJ",
          "Mobed A",
          "Charsouei S"
        ],
        "url": "https://pubmed.ncbi.nlm.nih.gov/40058719/"
      },
      {
        "title": "Preparation of novel anthraquinone-based aspirin derivatives with anti-cancer activity.",
        "year": 2021,
        "authors": [
          "Lin S",
          "Zhang Y",
          "Wang Z",
          "Zhang S",
          "Li Y",
          "Fan Y",
          "Li D",
          "Li S",
          "Bai Y"
        ],
        "url": "https://pubmed.ncbi.nlm.nih.gov/33741381/"
      }
    ],
    "summary": "Exploration of nanotechnology for aspirin delivery (nanosensors), repurposing for cancer therapy via structural modifications (anthraquinone derivatives), and ongoing studies on preventive roles in preeclampsia."
  },
  "patents": {
    "total_patents": 0,
    "recent_patents": [],
    "patent_trend": {},
    "summary": "Patent activity suggests growing interest in new applications."
  },
  "market_analysis": {
    "top_indications": [
      {
        "disease": "Anthraquinone-Based Anti-Cancer Repurposing",
        "market_size_usd_billion": 2e-7,
        "competition": "Big pharmaceutical company A (Anthraquinone derivatives), Oncology-focused biotech B (Targeted therapies), Generic drug manufacturer C (Cancer treatment lines)",
        "potential_score": 0.33
      }
    ],
    "summary": "Analysis of 1 potential indications completed. See top_indications for details."
  },
  "visualization_data": {
    "charts": {
      "trials_by_disease": {},
      "patent_trend": {},
      "market_potential": {}
    }
  },
  "report_links": {
    "pdf_report": "https://pharmamind.ai/reports/aspirin_report.pdf",
    "timestamp": "2025-10-29T04:44:06.273088"
  }
}